Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UIJ5 (
Rec
)
58,342
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although chondroitin sulfate proteoglycans (CSPGs) are major components of the embryonic extracellular matrix, little attention has been paid to specific CSPGs in early heart development, in part because appropriate antibodies were not available. Therefore we prepared specific polyclonal antibodies against chicken aggrecan, versican,
neurocan
, and phosphacan. Western blotting and immunohistochemical studies revealed the presence of aggrecan and versican in stages 12-21 chicken embryo hearts in distinctive spatial and temporal patterns. Because this is the first demonstration of aggrecan in heart tissue, we further used RT-PCR to confirm that aggrecan is expressed in the heart and in situ hybridization to confirm the pattern of expression determined using antibodies. Versican is found in the myocardium and the myocardial basement membrane. In contrast, aggrecan is specifically colocalized with several groups of migrating cells including endocardial cushion tissue cells, epicardial cells, a mesenchymal cell population in the outflow tract that may be of neural crest origin, and a mesenchymal cell population in the inflow tract. The combined observations indicate that versican and aggrecan are expressed in unique patterns and suggest that they play very different roles in development.
Anat
Rec
1999 12 01
PMID:Distinct spatial and temporal distributions of aggrecan and versican in the embryonic chick heart. 1058 23
The chondroitin sulfate proteoglycan (CSPG)
neurocan
was previously considered to be nervous-system specific. However, we have found
neurocan
in the embryonic heart and vasculature. In stage 11 quail embryos,
neurocan
was prominently expressed in the myocardium, dorsal mesocardium, heart-forming fields, splanchnic mesoderm, and vicinity of the extraembryonic vaculature, and at lower levels in the endocardium. A comparison of
neurocan
staining with QH1 staining of vascular endothelial cells demonstrates that
neurocan
is frequently expressed by cells adjacent to endothelial cells, rather than by endothelial cells themselves. In some cases, a dispersed subset of cells are
neurocan
-positive in a field of cells that otherwise appear uniform in morphology. Later in development,
neurocan
expression becomes relatively limited to the nervous system. However, even in 10-day embryos,
neurocan
is expressed in the chorio-allantoic membrane in the tissue that separates closely packed, small-diameter blood vessels. In summary, our results suggest that
neurocan
may function as a barrier that regulates vascular patterning during development.
Anat
Rec
A Discov Mol Cell Evol Biol 2003 Jun
PMID:Neurocan in the embryonic avian heart and vasculature. 1274 Sep 50